Karen Thibaudeau

This inventor holds 13 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Conjuchem, Inc., Conjuchem Biotechnologies Inc., Advanced Diagnostics and Discovery. Active years: 2002-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karen Thibaudeau. Retrieved from https://idiyas.com/inventor/karen-thibaudeau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 1)

% Patents Active = 38.5

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.7

ph-index = 9

Forward Citations = 512(Granted Patents)

Location History:

Montreal, CA (2002 - 2010)
Quebec, CA (2011)
Rosemere, CA (2007 - 2022)

Company Filing History:

Conjuchem Biotechnologies Inc.

patents

1 out of 1

Advanced Diagnostics and Discovery

patent

4. 1 out of 5

Prometic Biotherapeutics, Inc.

patents

Years Active: 2002-2022

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11291711 - Plasminogen replacement therapy for plasminogen-deficiency (2022-04-05),

2. 8039432 - Method of treatment of diabetes and/or obesity with reduced nausea side effect (2011-10-18),

3. 7982018 - Modified corticotropin releasing factor peptides and uses thereof (2011-07-19),

4. 7906482 - Anti-obesity agents (2011-03-15),

5. 7741286 - Long lasting anti-angiogenic peptides (2010-06-22),

6. 7737251 - Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders (2010-06-15),

7. 7601691 - Anti-obesity agents (2009-10-13),

8. 7256253 - Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components (2007-08-14),

9. 7144854 - Long lasting anti-angiogenic peptides (2006-12-05),

10. 7112567 - Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders (2006-09-26),

11. 6887470 - Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components (2005-05-03),

12. 6849714 - Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components (2005-02-01),

13. 6440417 - Antibodies to argatroban derivatives and their use in therapeutic and diagnostic treatments (2002-08-27),

Hello! How can I assist you today regarding innovations, inventions, inventors, patent attorneys, assignees, or patents?

Profile summary based on public USPTO records.